Want to quit smoking in 2024?
- Details
- Category: Research
A new study published in Addiction has found that cytisine, a low-cost, generic stop-smoking aid that has been used in eastern Europe since the 1960s, increases the chances of successful smoking cessation by more than two-fold compared with placebo and may be more effective than nicotine replacement therapy. It has a benign safety profile, with no evidence of serious safety concerns.
Oral peptides: A new era in drug development
- Details
- Category: Research
For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat surfaces or require specificity for particular protein homologs. Typically, larger biologics that can target these proteins demand injection, limiting patient convenience and accessibility.
Cancer test shows promise for bringing the benefits of immunotherapy to more patients
- Details
- Category: Research
Brigham researchers' findings from next-generation sequencing suggest that revising current cancer care guidelines could allow approximately 6,000 more patients in the U.S. to benefit from immunotherapy treatment each year.
Immunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identifies more cancer patients who could benefit from this form of therapy.
Organic chemistry research transformed: The convergence of automation and AI reshapes scientific exploration
- Details
- Category: Research
Recently, National Science Open magazine published online a review article led by Professor Fanyang Mo (School of Materials Science and Engineering, Peking University) and Professor Yuntian Chen (Eastern Institute of Technology, Ningbo). The research team proposed a significant shift towards automation and artificial intelligence (AI) in organic chemistry over the past decade.
Natto consumption suppresses arteriosclerosis
- Details
- Category: Research
Atherosclerosis, a chronic condition characterized by the accumulation of lipid and inflammatory cells within the blood vessel walls, causes cardiovascular diseases, such as heart disease and stroke. Natto, a food rich in vitamin K2, has shown promise in mitigating cardiovascular diseases by enhancing arterial flexibility and modulating inflammatory responses.
Outsize benefit seen in trial of drug for kidney disease
- Details
- Category: Research
In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria - albumin in urine, a sign of kidney damage - for 50% of participants. When the experimental drug was paired with a standard-care medication, 70% of participants reportedly experienced a significant reduction in albuminuria.
Enzymes can't tell artificial DNA from the real thing
- Details
- Category: Research
The genetic alphabet contains just four letters, referring to the four nucleotides, the biochemical building blocks that comprise all DNA. Scientists have long wondered whether it’s possible to add more letters to this alphabet by creating brand-new nucleotides in the lab, but the utility of this innovation depends on whether or not cells can actually recognize and use artificial nucleotides to make proteins.
More Pharma News ...
- Major breakthrough for severe asthma treatment
- The risk of cardiovascular disease can be reduced by eating more oily fish
- New technique efficiently offers insight into gene regulation
- A patch of protection against Zika virus
- Scientists uncover how fermented-food bacteria can guard against depression, anxiety
- AI may spare breast cancer patients unnecessary treatments
- Lidocaine may be able to kill certain cancer cells by activating bitter taste receptors